0      0


3446 - LX9211, an Orally-Administered, Non-opioid, AAK1 Inhibitor for Painful Diabetic Peripheral Neuropathy—Results from a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study


‐ Jun 23, 2023 5:45pm


Speaker(s):

You must be logged in and own this session in order to post comments.